Drug Company to Share Revenues With Indigenous People Who Donated Their Genes
Read more at The New York Times
Topics
-
What Matters More for Longevity: Genes or Lifestyle?
It depends on what your goal is.The New York Times - 1h -
J&J says its lung cancer drug combination keeps people alive longer
Johnson & Johnson said its lung cancer regimen – Rybrevant plus Lazcluze – keeps people alive for at least a year longer than AstraZeneca's Tagrisso.CNBC - 19h -
Tencent shares fall 8% in Hong Kong after U.S. designates it a Chinese military company
Other Chinese companies added to the list included battery maker CATL, which is part of the supply chain for automakers like Ford and Tesla.CNBC - 1d -
This is how we do it: ‘We don’t share the intimate details of the sex we have with other people’
Lachlan and Agnes are in an ethical non-monogamous relationship but get frustrated when couples exploit the concept as a tool for bad behaviour. How do you do it? Share the story of your sex ...The Guardian - 3d -
Tesla shares fall as company reports first decline in annual deliveries
Reduced European subsidies, a US shift to lower-priced hybrids and Chinese competition have squeezed EV maker. Tesla reported its first decline in annual deliveries on Thursday, as the automaker ...The Guardian - 5d -
Gunman who killed at least 12 people in Montenegro rampage dies by suicide
A gunman who fatally shot at least 12 people, including two children, in Montenegro has killed himself while surrounded by police, officials said Thursday.NBC News - 6d -
Americans keep flocking to Florida—3 young people share what it's like living there: 'My money goes a long way'
Florida's population has continued to boom despite costs going up and hurricanes intensifying.CNBC - 6d -
Scopely scores a billion downloads and $10B in revenue to date
Scopely announced several key milestones achieved to date: $10 billion in lifetime revenue for its mobile games and a billion downloads.VentureBeat - Dec. 30
More from The New York Times
-
First Bird Flu Death in U.S. Reported in Louisiana
The deceased was over 65 and had other medical conditions, state officials said.The New York Times - 1d -
Abortion Pills Prescribed by Pharmacists Are Newest Effort in Abortion Fight
Washington State’s program is the first, but other states are expected to try allowing pharmacists to prescribe the pills to counter growing efforts to curtail abortion access.The New York Times - 19h -
A Ballerina Prized for Her Musicality Deals With Hearing Loss
Sara Mearns, the New York City Ballet principal, announced her 10-year struggle on Instagram. She tested out her new hearing aids in “The Nutcracker.”The New York Times - 1d -
24, and Trying to Outrun Schizophrenia
Early intervention tries to rein in psychotic disorders before they can ruin young lives. For Kevin Lopez, everything is on the line.The New York Times - 2d -
Are Childhood Vaccines ‘Overloading’ the Immune System? No.
Vaccines today are more efficient and contain far fewer stimulants to the immune system than some used decades ago.The New York Times - Dec. 14
More in Health
-
Abortion Pills Prescribed by Pharmacists Are Newest Effort in Abortion Fight
Washington State’s program is the first, but other states are expected to try allowing pharmacists to prescribe the pills to counter growing efforts to curtail abortion access.The New York Times - 19h -
IV fluid shortage likely to extend into early 2025
This is a MedPage Today story. In late September, Hurricane Helene damaged a major supplier of intravenous (IV) fluids. In this report, we follow up on what has happened since. Hurricane Helene ...ABC News - 20h -
First Bird Flu Death in U.S. Reported in Louisiana
The deceased was over 65 and had other medical conditions, state officials said.The New York Times - 1d -
A Ballerina Prized for Her Musicality Deals With Hearing Loss
Sara Mearns, the New York City Ballet principal, announced her 10-year struggle on Instagram. She tested out her new hearing aids in “The Nutcracker.”The New York Times - 1d -
Fewer than 1 in 1,000 US adolescents receive gender-affirming medications, researchers find
Fewer than 1 in 1,000 U.S. adolescents with commercial insurance received gender-affirming medications during a recent five-year periodABC News - 1d